These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


1063 related items for PubMed ID: 26206089

  • 1. miR-216a rescues dexamethasone suppression of osteogenesis, promotes osteoblast differentiation and enhances bone formation, by regulating c-Cbl-mediated PI3K/AKT pathway.
    Li H, Li T, Fan J, Li T, Fan L, Wang S, Weng X, Han Q, Zhao RC.
    Cell Death Differ; 2015 Dec; 22(12):1935-45. PubMed ID: 26206089
    [Abstract] [Full Text] [Related]

  • 2. Dexamethasone suppresses osteogenesis of osteoblast via the PI3K/Akt signaling pathway in vitro and in vivo.
    Pan JM, Wu LG, Cai JW, Wu LT, Liang M.
    J Recept Signal Transduct Res; 2019 Feb; 39(1):80-86. PubMed ID: 31210570
    [Abstract] [Full Text] [Related]

  • 3. miR-16-2* Interferes with WNT5A to Regulate Osteogenesis of Mesenchymal Stem Cells.
    Duan L, Zhao H, Xiong Y, Tang X, Yang Y, Hu Z, Li C, Chen S, Yu X.
    Cell Physiol Biochem; 2018 Feb; 51(3):1087-1102. PubMed ID: 30476907
    [Abstract] [Full Text] [Related]

  • 4. MiR-27a is Essential for the Shift from Osteogenic Differentiation to Adipogenic Differentiation of Mesenchymal Stem Cells in Postmenopausal Osteoporosis.
    You L, Pan L, Chen L, Gu W, Chen J.
    Cell Physiol Biochem; 2016 Feb; 39(1):253-65. PubMed ID: 27337099
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. MiR-125b Regulates the Osteogenic Differentiation of Human Mesenchymal Stem Cells by Targeting BMPR1b.
    Wang H, Xie Z, Hou T, Li Z, Huang K, Gong J, Zhou W, Tang K, Xu J, Dong S.
    Cell Physiol Biochem; 2017 Feb; 41(2):530-542. PubMed ID: 28214897
    [Abstract] [Full Text] [Related]

  • 7. MicroRNA-200c promotes osteogenic differentiation of human bone mesenchymal stem cells through activating the AKT/β-Catenin signaling pathway via downregulating Myd88.
    Xia P, Gu R, Zhang W, Shao L, Li F, Wu C, Sun Y.
    J Cell Physiol; 2019 Dec; 234(12):22675-22686. PubMed ID: 31152447
    [Abstract] [Full Text] [Related]

  • 8. Osteogenic differentiation of human adipose tissue-derived stem cells is modulated by the miR-26a targeting of the SMAD1 transcription factor.
    Luzi E, Marini F, Sala SC, Tognarini I, Galli G, Brandi ML.
    J Bone Miner Res; 2008 Feb; 23(2):287-95. PubMed ID: 18197755
    [Abstract] [Full Text] [Related]

  • 9. Loss of Cbl-PI3K interaction modulates the periosteal response to fracture by enhancing osteogenic commitment and differentiation.
    Scanlon V, Walia B, Yu J, Hansen M, Drissi H, Maye P, Sanjay A.
    Bone; 2017 Feb; 95():124-135. PubMed ID: 27884787
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. miR-17-5p and miR-106a are involved in the balance between osteogenic and adipogenic differentiation of adipose-derived mesenchymal stem cells.
    Li H, Li T, Wang S, Wei J, Fan J, Li J, Han Q, Liao L, Shao C, Zhao RC.
    Stem Cell Res; 2013 May; 10(3):313-24. PubMed ID: 23399447
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Glimepiride promotes osteogenic differentiation in rat osteoblasts via the PI3K/Akt/eNOS pathway in a high glucose microenvironment.
    Ma P, Gu B, Xiong W, Tan B, Geng W, Li J, Liu H.
    PLoS One; 2014 May; 9(11):e112243. PubMed ID: 25391146
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 54.